| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/14/2011 | CA2297786C New immunoprotective influenza antigen and its use in vaccination |
| 06/14/2011 | CA2293829C Methods and compositions for galactosylated glycoproteins |
| 06/14/2011 | CA2210732C Recombinant swinepox virus |
| 06/09/2011 | WO2011069104A2 Multispecific antibodies, antibody analogs, compositions, and methods |
| 06/09/2011 | WO2011069090A1 Inhibition of the activation of coagulation factor xii by ligands of phosphatidylserine |
| 06/09/2011 | WO2011069074A2 Methods of treating metastatic breast cancer with trastuzumab-mcc-dm1 |
| 06/09/2011 | WO2011069019A2 J591 minibodies and cys-diabodies for targeting human prostate specific membrane antigen (psma) and methods for their use |
| 06/09/2011 | WO2011068953A2 Atoxic recombinant holotoxins of clostridium difficile as immunogens |
| 06/09/2011 | WO2011068934A2 Vaccine against neoplastic or cancerous lesions caused by human papillomavirus (hpv), procedures, uses and methods |
| 06/09/2011 | WO2011068894A2 Novel curcumin-antibody conjugates as anti-cancer agents |
| 06/09/2011 | WO2011068870A2 Modulation of nk cell antigen specific effector activity by modulation of cxcr6 (cd186) |
| 06/09/2011 | WO2011068845A1 Combining radioimmunotherapy and antibody-drug conjugates for improved cancer therapy |
| 06/09/2011 | WO2011068840A1 Methods for treating cancers comprising k-ras mutations |
| 06/09/2011 | WO2011068143A1 Antibody against influenza virus subtype h5 and use thereof |
| 06/09/2011 | WO2011068136A1 Pharmaceutical agent comprising antibody capable of binding specifically to ganglioside gd3 |
| 06/09/2011 | WO2011067933A1 Mybl2 peptides and vaccines containing the same |
| 06/09/2011 | WO2011067920A1 Imp-3 oligopeptides and vaccines including the same |
| 06/09/2011 | WO2011067616A1 Therapies for preventing or suppressing clostridium difficile infection |
| 06/09/2011 | WO2011067446A1 Method for the identification of animals vaccinated against brucella |
| 06/09/2011 | WO2011067224A1 Inactivated poultry vaccine |
| 06/09/2011 | WO2011067161A1 Prostate cancer dna vaccine |
| 06/09/2011 | WO2011067160A1 Von willebrand factor specific binding agents and uses thereof |
| 06/09/2011 | WO2011066995A1 Malaria vaccines based on apicomplexan ferlins, ferlin-like proteins and other c2-domain containing proteins |
| 06/09/2011 | WO2011066783A1 Anti-cyr61 protein monoclonal antibodies and uses thereof |
| 06/09/2011 | WO2011066721A1 Antl-igf-ir antibodies and uses thereof |
| 06/09/2011 | WO2011066711A1 Specific antigen of clonorchis sinensis and uses thereof |
| 06/09/2011 | WO2011066615A1 Methods and compositions for increasing titer of recombinant porcine adenovirus-3 vectors |
| 06/09/2011 | WO2011041886A8 Vaccines comprising heat-sensitive transgenes |
| 06/09/2011 | WO2011041003A9 Compositions and methods for preparing staphylococcus aureus serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions |
| 06/09/2011 | WO2011024072A3 Hybrid polypeptides including meningococcal fhbp sequences |
| 06/09/2011 | WO2011009119A9 Compositions and methods for diagnosing and treating fibrotic disorders |
| 06/09/2011 | WO2011005341A3 Compositions and methods related to protein a (spa) variants |
| 06/09/2011 | WO2010060186A8 Antibodies that specifically block the biological activity of a tumor antigen |
| 06/09/2011 | WO2003043587A9 Recovery of recombinant human parainfluenza virus type 1 (hpiv1) from cdna |
| 06/09/2011 | US20110137406 Bioactive stents for type ii diabetics and methods for use thereof |
| 06/09/2011 | US20110137291 Use of relaxin to increase arterial compliance |
| 06/09/2011 | US20110137014 Super humanized antibodies |
| 06/09/2011 | US20110136743 Survivin, a protein that inhibits cellular apoptosis, and its modulation |
| 06/09/2011 | US20110136173 Novel Method for the Stabilization of Chimeric Immunoglobulins or Immunoglobulin Fragments, and Stabilized Anti-EGP-2 SCFV Fragment |
| 06/09/2011 | US20110135715 Defensin-antigen fusion proteins |
| 06/09/2011 | US20110135712 Biologically Active Taxane Analogs And Methods Of Treatment By Oral Administration |
| 06/09/2011 | US20110135692 Anti-tumor immunotherapy |
| 06/09/2011 | US20110135691 Immunomodulation by iap inhibitors |
| 06/09/2011 | US20110135690 Extracellular matrix adjuvant & methods for prevention and/or inhibition of ovarian tumors and ovarian cancer |
| 06/09/2011 | US20110135689 Vaccine, therapeutic composition and methods for treating or inhibiting francisella tularenis |
| 06/09/2011 | US20110135688 Methods and Compositions for Increasing Titer of Recombinant Porcine Adenovirus-3 Vectors |
| 06/09/2011 | US20110135687 Rapid, efficient purification of hsv-specific t-lymphocytes and hsv antigens identified via same |
| 06/09/2011 | US20110135686 Replication-Defective Flavivirus Vaccines and Vaccine Vectors |
| 06/09/2011 | US20110135685 Edible Vaccines Expressed in Soybeans |
| 06/09/2011 | US20110135684 Use of L-alpha-lysophosphatidylcholine to obtain the differentiation of monocytes in mature dendritic cells in vitro |
| 06/09/2011 | US20110135683 Modified vaccinia virus ankara for the vaccnation of neonates |
| 06/09/2011 | US20110135682 Recombinant Bicistronic Flaviviruses and Methods of Use Thereof |
| 06/09/2011 | US20110135680 Deletion mutants of flagellin and methods of use |
| 06/09/2011 | US20110135679 Compositions for inducing immune responses |
| 06/09/2011 | US20110135678 Tolerizing agents |
| 06/09/2011 | US20110135677 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 06/09/2011 | US20110135676 Novel antiviral peptide against avian influenza virus h9n2 |
| 06/09/2011 | US20110135675 Melanoma associated peptide analogues and vaccines against melanoma |
| 06/09/2011 | US20110135674 Markers of XMRV Infection and Uses Thereof |
| 06/09/2011 | US20110135673 Epitope protection assay |
| 06/09/2011 | US20110135672 Hla-g compositions and methods of use thereof |
| 06/09/2011 | US20110135671 Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases |
| 06/09/2011 | US20110135670 Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases |
| 06/09/2011 | US20110135669 Synthetic agonists of tlr9 |
| 06/09/2011 | US20110135668 Compounds and compositions as protein kinase inhibitors |
| 06/09/2011 | US20110135667 Anti-cd79b antibodies and immunoconjugates and methods of use |
| 06/09/2011 | US20110135666 Regulatory b cells and their uses |
| 06/09/2011 | US20110135665 Methods for treating reperfusion injuries |
| 06/09/2011 | US20110135664 Monoclonal antibodies against the rgm a protein for use in the treatment of retinal nerve fiber layer degeneration |
| 06/09/2011 | US20110135663 Anti-igf-ir antibodies and uses thereof |
| 06/09/2011 | US20110135662 FUNCTION MODIFYING NAv 1.7 ANTIBODIES |
| 06/09/2011 | US20110135661 Treatment and prevention of dry age-related macular degeneration by activating cd36 |
| 06/09/2011 | US20110135660 Prevention and treatment of synucleinopathic disease |
| 06/09/2011 | US20110135659 Fish Vaccine |
| 06/09/2011 | US20110135658 Vhz for diagnosis and treatment of cancers |
| 06/09/2011 | US20110135657 Human antigen binding proteins that bind beta-klotho, fgf receptors and complexes thereof |
| 06/09/2011 | US20110135656 Method of treating cancer |
| 06/09/2011 | US20110135655 Role of PI3K p110 delta Signaling in Retroviral Infection and Replication |
| 06/09/2011 | US20110135654 Prostate cancer related gene styk1 |
| 06/09/2011 | US20110135653 Antibodies Against HER2 Truncated Variant CTF-611 |
| 06/09/2011 | US20110135652 Novel Use of Idbf |
| 06/09/2011 | US20110135651 Method and composition for enhancing hematopoietic stem cell mobilization |
| 06/09/2011 | US20110135650 Morpholinone compounds as factor ixa inhibitors |
| 06/09/2011 | US20110135649 Vascular Endothelial Growth Factor C (VEGF-C) Protein and Gene, Mutants Thereof, and Uses Thereof |
| 06/09/2011 | US20110135648 Anti-neublastin antibodies and uses thereof |
| 06/09/2011 | US20110135647 Genes and polypeptides relating to breast cancers |
| 06/09/2011 | US20110135646 Genes of an Otitis Media Isolate of Nontypeable Haemophilus influenzae |
| 06/09/2011 | US20110135645 Human antibodies neutralizing human metapneumovirus |
| 06/09/2011 | US20110135644 Methods and compositions for enhanced delivery of macromolecules |
| 06/09/2011 | US20110135643 Methods and compositions for prostate cancer immunotherapy |
| 06/09/2011 | US20110135642 Pharmaceutical Compositions Comprising Antibodies Binding To EBV (Ebstein-Barr Virus) Protein BARF1 |
| 06/09/2011 | US20110135641 Radioprotectants targeting thrombospondin-1 and cd47 |
| 06/09/2011 | US20110135640 Identification of tumour-associated cell surface antigens for diagnosis and therapy |
| 06/09/2011 | US20110135639 B lymphocyte stimulator assays |
| 06/09/2011 | US20110135638 Actriib proteins and variants and uses therefore relating to utrophin induction for muscular dystrophy therapy |
| 06/09/2011 | US20110135637 Trimodal cancer therapy |
| 06/09/2011 | US20110135636 Recombinant Anti-Epidermal Growth Factor Receptor Antibody Compositions |
| 06/09/2011 | US20110135635 Anti-alpha2 integrin antibodies and their uses |
| 06/09/2011 | US20110135634 Methods of inhibiting infection by diverse subtypes of drug-resistant hiv-1 |
| 06/09/2011 | US20110135633 Chronic lymphocytic leukemia cell line |